PCR Journal Club

The STRENGTH study is a multicentre prospective randomised trial investigating whether RenalGuard is superior to standard intravenous hydration in preventing contrast induced nephropathy in patients with chronic kidney disease (CKD) undergoing complex cardiovascular procedures.

The ST-OHCA study is a single centre prospective study investigating the incidence, timing and predictors of definite stent thrombosis in comatose survivors of out-of-hospital cardiac arrest (OHCA) undergoing immediate PCI and therapeutic hypothermia.

Part I of the 16th EBC consensus document presents a detailed analysis of possible pitfalls associated with each step of the provisional single stent approach and it provides a compendium of the pertinent strategies for rescue and prevention. Also included in this review: lead author Remo Albiero...

Although the default strategy remains a stepwise provisional strategy, the authors of the 16th expert consensus document recognize that up to 25 % of all single stent approaches eventually require a second.

This analysis of the large multinational Prospective Global Registry for the Study of Chronic Total Occlusion Intervention (PROGRESS‐CTO) registry1 examined prevalence, temporal trends, and clinical outcomes of radial versus femoral access in CTO PCI.

This retrospective observational study was undertaken in patients referred for transradial coronary angiography (CA) or PCI to assess the impact of sheath sizes and haemostasis techniques on RAO incidence.

In this paper, the authors investigated the comparative efficacy and safety of TRA versus TFA in ACS patients undergoing complex PCI in the Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX (MATRIX)-Access trial1.

DEFINITION II was a randomised control trial comparing PCI in complex bifurcation lesions using a two-stent technique versus a provisional stenting strategy. At one year follow-up, a two-stent technique was superior to a provisional approach in true complex bifurcations. Here, the authors present the 3-year clinical outcomes...

The CASTLE trial is a randomised multicentre prospective non-inferiority trial comparing ultra-thin strut bioresorbable polymer and thin strut durable polymer drug eluting stents implanted with intracoronary imaging guidance.

As the relationship between leaflet length and annular dimension becomes highly relevant in TR pathophysiology, the present study aimed to evaluate the impact of tricuspid leaflet-to-annulus mismatch on outcomes after T-TEER.